A REVIEW ON METHOD DEVELOPMENT AND VALIDATION OF FAVIPIRAVIR BULK AND THEIR TABLET DOSAGE FORM
Author(s):
Loganathan A, NALLA KUMAR P, PONNILAVARASAN I, VIGNESH S, GOWTHAM D
Keywords:
RP-HPLC, UV, RP-UPLC, NMR\LC-MS,UPLC.
Abstract
Favipiravir is an antiviral drug that was initially developed for influenza by Toyama Chemical, which has recently garnered much attention, especially in India, is an anti-viral drug originally designed for influenza, called Favipiravir. In this article, we have tried to provide a complete, evidence-based review of this drug in the perspective of the present pandemic to give further details about its role in the management of COVID-19. Favipiravir is a very widely used pharmaceutical, consequently it has been detected in the water system. The aim of this review is to focus on update of determination of Favipiravir in bulk and in pharmaceutical preparations using chromatographic and spectrophotometric methods. Favipiravir are estimated by RP-HPLC, UV, HPLC, RP-HPLC,UPLC, methods. For subjective and quantitative estimation of Favipiravir these diagnostic techniques can be utilized. This review provides detailed information on separation conditions for Favipiravir in the presence of drug and in presence of its degradation products.
Article Details
Unique Paper ID: 158529

Publication Volume & Issue: Volume 9, Issue 9

Page(s): 615 - 620
Article Preview & Download


Share This Article

Join our RMS

Conference Alert

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024

Last Date: 15th March 2024

Call For Paper

Volume 10 Issue 10

Last Date for paper submitting for March Issue is 25 June 2024

About Us

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org

Social Media

Google Verified Reviews